Evidence map›Paper›PMID 40657675›Full record

ArticleJournal of applied clinical medical physics2025

Evaluation of the TrueBeam machine-performance-check (MPC): Collimator device check (CDC).

Michael Barnes, Andrew Dipuglia, Brad Beeksma, Joerg Lehmann

Abstract readEvaluation Study
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael BarnesDepartment of Radiation Oncology, Calvary Mater Hospital Newcastle, Newcastle, New South Wales, Australia.ORCID https://orcid.org/0000-0003-0924-897X
Andrew DipugliaDepartment of Radiation Oncology, Calvary Mater Hospital Newcastle, Newcastle, New South Wales, Australia.
Brad BeeksmaDepartment of Radiation Oncology, Calvary Mater Hospital Newcastle, Newcastle, New South Wales, Australia.ORCID https://orcid.org/0009-0000-3652-7339
Joerg LehmannDepartment of Radiation Oncology, Calvary Mater Hospital Newcastle, Newcastle, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the Varian machine performance check (MPC) collimator devices check (CDC) for routine MLC and jaw testing as part of an AAPM compliant linac QA program.

methodsCDC MLC positioning, MLC backlash, jaw positioning, and jaw parallelism were each assessed for repeatability and concordance with conventional QA. MLC and jaw positioning were also assessed for sensitivity. Measurement time and repeatability of CDC were assessed by timing and recording five successive measurements on a single linac. Concordance was assessed monthly over 5 months on four linacs, conducted during the same session as conventional QA. MLC positioning was compared to an advanced picket fence test, while jaw positioning and parallelism were compared to department in-house EPID based methods. MLC backlash was compared to the Varian built-in method. Sensitivity was assessed via deliberately introduced errors except for MLC backlash, which was assessed via correlation between methods across leaf banks.

resultsCDC requires 4:09 (min:s) ± 1.8 s (2 SD) to perform. Repeatability was measured to be: 0.02 mm for both MLC positioning and backlash, 0.15 mm for jaw positioning and 0.009° for jaw parallelism (2 SD). Concordance was observed for mean MLC positioning to within 0.32 , 0.08 mm for MLC backlash, 0.6 mm for jaw positioning and 0.06° for jaw parallelism. MLC and jaw positioning sensitivity were observed with maximum mean difference between methods of 0.18  and 0.71 mm, respectively. MLC backlash correlation coefficient between methods across leaf banks was observed to 0.84 and 0.9 for banks A and B, respectively.

conclusionMPC CDC has been demonstrated to provide acceptably equivalent MLC and jaw positioning assessment to standard methods and could conceivably be used in a linac QA program for these purposes.

Indexed as

NeoplasmsParticle AcceleratorsPhantoms, ImagingQuality Assurance, Health CareRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosageMLCMPCPicket FenceQA

Identifiers

PMID40657675
PMCPMC12257350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.